Evidence map›Paper›PMID 39304239›Full record

Trial reportThe Lancet. Global health2024

Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial.

Augustine T Choko, Kathryn L Dovel, Sekeleghe Kayuni, Donaldson F Conserve, Anthony Buttterworth, Amaya L Bustinduy, J Russell Stothard, Wala Kamchedzera, Madalo Mukoka-Thindwa, James Jafali and 4 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Lancet. Global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Augustine T ChokoPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: achoko@mlw.mw.
Kathryn L DovelDivision of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; Partners in Hope, Lilongwe, Malawi.
Sekeleghe KayuniDepartment of Medicine, Medical Aid Society of Malawi, Blantyre, Malawi.
Donaldson F ConserveDepartment of Prevention and Community Health, George Washington University, Washington, DC, USA.
Anthony ButtterworthPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Amaya L BustinduyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
J Russell StothardDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Wala KamchedzeraPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Madalo Mukoka-ThindwaPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
James JafaliPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Department of Clinical Infection, Microbiology & Immunology, University of Liverpool, Liverpool, UK.
Peter MacPhersonPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; School of Health & Wellbeing, University of Glasgow, Glasgow, UK.
Katherine FieldingDepartment of Infectious Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Nicola DesmondPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Elizabeth L CorbettPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Funding

Wellcome Trust 216458
6 · The paper itself

Abstract

backgroundUndiagnosed HIV and schistosomiasis are highly prevalent among fishermen in the African Great Lakes region. We aimed to evaluate the efficacy of lakeside interventions integrating services for HIV and male genital schistosomiasis on the prevalence of schistosomiasis, uptake of antiretroviral therapy (ART) for HIV, and voluntary male medical circumcision (VMMC) among fishermen in Malawi.

methodsWe conducted a three-arm, cluster-randomised trial in 45 lakeshore fishing communities (clusters) in Mangochi, Malawi. Clusters were defined geographically by their home community as the place where fishermen leave their boats (ie, a landing site). Eligible participants were male fishermen (aged ≥18 years) who resided in a cluster. Clusters were randomly allocated (1:1:1) through computer-generated random numbers to either enhanced standard of care (SOC), which offered invitation with information leaflets to a beach clinic offering HIV testing and referral, and presumptive treatment for schistosomiasis with praziquantel; peer education (PE), in which a nominated fisherman was responsible for explaining the study leaflet to promote services to his boat crew; or peer distribution education (PDE), in which the peer educator explained the leaflet and distributed HIV self-test kits to his boat crew. The beach clinic team and fishermen were not masked to intervention allocation; however, investigators were masked until the final analysis. Coprimary composite outcomes were the proportion of participants who had at least one Schistosoma haematobium egg observed on light microscopy from 10 mL of urine filtrate and the proportion who had self-reported initiating ART or scheduling VMMC by day 28. Outcomes were analysed by intention to treat; multiple imputation for missing outcomes was done; random-effect binomial models adjusting for baseline imbalance and clustering were used to compute unadjusted and adjusted risk differences, risk ratios (RRs) and 95% CIs, and intracluster correlation coefficients for each outcome. This trial is registered with ISRCTN, ISRCTN14354324.

findingsBetween March 1, 2022, and Jan 29, 2023, 45 (65·2%) of 69 clusters assessed for eligibility were enrolled in the trial, with 15 clusters per arm. Of the 6036 fishermen screened at baseline, 5207 (86·3%) were eligible for participation: 1745 (87·6%) of 1991 in the enhanced SOC group, 1687 (81·9%) of 2061 in the PE group, and 1775 (89·5%) of 1984 in the PDE group. Compared with the prevalence of active schistosomiasis in the enhanced SOC group (292 [16·7%] of 1745), 241 (13·6%) of 1775 fishermen in the PDE group (adjusted RR 0·80 [95% CI 0·69-0·94]; p=0·0054) and 263 (15·6%) of 1687 fishermen in the PE group (0·92 [0·79-1·07]; p=0·28) had schistosomiasis at day 28. 230 (13·2%) in the enhanced SOC group, 281 (16·7%) in the PE group, and 215 (12·1%) in the PDE group initiated ART or were scheduled for VMMC. ART initiation or VMMC scheduling was not significantly increased with the PDE intervention (0·88 [0·74-1·05); p=0·15) and was marginally increased with the PE intervention (1·16 [0·99-1·37]; p=0·069) when compared with the enhanced SOC group. No serious adverse events were reported in this trial.

interpretationWe found weak evidence for the use of peer education to increase uptake of ART and VMMC, but strong evidence for the added distribution of HIV self-test kits to promote high engagement with services and reduce the prevalence of active schistosomiasis, suggesting a high potential for scale-up in hard-to-reach communities across Malawi.

fundingWellcome Trust and the UK National Institute for Health Research.

Indexed as

HIV InfectionsPraziquantelAdolescentAdultAnthelminticsCluster AnalysisFisheriesHIV TestingHumansMalawiMaleMiddle AgedPrevalenceSchistosomiasisYoung AdultAnthelminticsPraziquantel

Identifiers

PMID39304239
PMCPMC11420466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.